| Beating the Stem Cell Drum
October 28, 2009 at 7:00 pm
|
| | PR practitioners for California stem cell researchers moved quickly today to tout the disease team awards to their institutions and businesses. Here is an initial list of links to the various news releases we have seen, along with institutions yet to be heard from.Novocell, $20 million shared with UCSFSalk Institute. $16 millionSangamo Biosciences, of Richmond, Ca., $14.6 million, shared with |
| A Peek at News Coverage of CIRM's $230 Million Disease Team Round
October 28, 2009 at 6:29 pm
|
| | California's stem cell research effort today climbed over the $1 billion mark with its whopping disease team round. The awards began generating news coverage internationally this afternoon, and more stories will surface later today and tomorrow.Erika Check Hayden filed a report on Nature magazine's breaking news blog. She said CIRM regards the round as the "crown jewel of its portfolio." She said |
| CIRM News Release: More than $250 Million in Disease Team Round, Including International Partners
October 28, 2009 at 2:44 pm
|
| | The California stem cell agency has posted its press release on the largest research round in its history.The release notes that, with funding from international partners, the total comes to more than $250 million. The release also contains the identities of all the winning researchers and their institutions. |
| CIRM News Conference Link
October 28, 2009 at 2:30 pm
|
| | Here is a link to the live news conference on CIRM's $230 million disease team program. |
| California Stem Cell Agency Approves $230 Million Aimed at Clinical Trials
October 28, 2009 at 2:24 pm
|
| | The California stem cell agency today formally awarded $230 million to 14 teams of scientists in the largest and most ambitious round of research grants in CIRM history.Already the world's largest source of funding for human embryonic stem cell research, the $3 billion agency said the grants and loans would lead to the beginning stage of clinical trials in four years.The disease team round also |
| Concerns About Size of Disease Team Round
October 28, 2009 at 1:42 pm
|
| | Some CIRM directors seem to be concerned about the overall size of the disease team package and the original budget of $210 million. There may well be an effort to trim the overall size, which would mean that some grants in tier one are removed. Normally all grants in tier win ultimate approval from directors, but they have the ability to do whatever they want. |
| City of Hope Wins Initial Appeal
October 28, 2009 at 1:19 pm
|
| | Directors of the California stem cell agency this morning gave a positive nod to an attempt to win approval of an application from the City of Hope in the agency's disease team round. The board approved, on a unanimous vote, a motion to move the application into the first tier of grants expected to be approved later today. The grant was proposed by Karen Aboody of City of Hope in Duarte, Ca., to |
| City of Hope Grant Being Discussed
October 28, 2009 at 1:10 pm
|
| | The CIRM board is now discussing an appeal on a grant proposal by Karen Aboody of the City of Hope. |
| CIRM Directors Nix Buck Appeal
October 28, 2009 at 12:21 pm
|
| | Directors of the California stem cell agency turned back an attempt to win approval of a $17 million application from the Buck Institute on a stem cell research proposal involving Parkinsons disease. The board rejected, on a 6-11 vote with one abstention, a motion to move the application into the first tier of grants expected to be approved later today.The grant was proposed by Xianmin Zeng of |
| Buck Institute Application Being Discussed
October 28, 2009 at 11:29 am
|
| | The board of the California stem cell agency has resumed its discussion of disease team grants and loans. Currently it is considering an effort by Xianmin Zeng of the Buck Institute for Age Research to overturn a negative decision on her application by science reviewers. |
| Looking at CIRM Grant Appeals Issues
October 28, 2009 at 9:36 am
|
| | Here are links to documents relating to the California stem cell agency and complaints about fairness in its grant review process.Text of CIRM policy on appeals via "extraordinary petition."An October 2008 examination of transparency and conflict of interest issuesConsumer Watchdog Identifies Businesses Rejected for CIRM GrantsFirst ever successful conflict appeal, December 2008CIRM's August 2008 |
| Weissman's $20 Million Proposal Dodges Rejection
October 28, 2009 at 1:36 am
|
| | A $20 million grant application from reknown scientist Irv Weissman of Stanford tonight avoided disaster as CIRM directors overturned a decision by scientific reviewers to reject the proposal.The application was moved, 14-2 vote with two directors abstaining, into the top tier of disease team grants that are headed for approval by the directors tomorrow morning.Another $20 million application |
| Correction
October 28, 2009 at 1:25 am
|
| | The "public appeal" item on Oct. 27, 2009, incorrectly said that extraordinary petitions filed by six grant applicants were not available on the CIRM Web site. The petitions were not noted on the CIRM board agenda but could be found three layers down on six of the 20 summaries of the grants rejected by reviewers. |
| Weissman's Grant and Appeal Now Being Discussed
October 28, 2009 at 12:10 am
|
| | Currently being discussed by the CIRM board is a rejected grant (1485) by noted Stanford scientist Irv Weissman. |
| Advisory
October 27, 2009 at 11:54 pm
|
| | The meeting of the California stem cell agency board has resumed with much improved clarity. Up for discussion are the $167 million in disease team grants and loans. |
| Six Rejected Grant Applicants Make Public Appeal to CIRM Board
October 27, 2009 at 11:39 pm
|
| | Six research teams that lost out in CIRM's closed door reviews of their applications for up to $20 million dollars are now seeking to overturn the decisions.The rejected applicants include three from Stanford(Irv Weissman, Judith Shizuru and Gary Steinberg), one from the City of Hope (Karen S. Aboody) in Duarte, Ca., one from UC Irvine(Aileen Anderson) and one from the Buck Institute(Xianmin Zeng | | | 
|
No comments:
Post a Comment